InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-2.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Herman James L, Responsable de la Conformité. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Aggregated, 5 disclosures have been published. Activity tracked since 17 March 2021. The latest transaction was disclosed on 23 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
1,186 shares@ US$1.819.3% of flowCommon StockSEC:0001214659-24-005215:0
1,280 shares@ US$1.9210.9% of flowCommon StockSEC:0001209191-23-020346:0
1,280 shares@ US$2.740.0039% mcap18.6% of flowCommon StockSEC:0001209191-22-026142:0
2,560 shares@ US$3.220.0085% mcap40.7% of flowCommon StockSEC:0001209191-21-039926:0
2,560 shares@ US$3.2232.5% of flowCommon StockSEC:0001209191-21-039926
5 of 5 declarations
About Herman James L
James L. Herman is the Vice President and Chief Compliance Officer of Cumberland Pharmaceuticals Inc. In this role, he oversees compliance affairs and ensures that the company adheres to regulatory requirements. Herman brings expertise in regulatory compliance and risk management, contributing to the protection of the company's interests and its stakeholders. His commitment to transparency and accountability is essential to maintain investor confidence.
